
LivAi's cloud-based AI oncology software, MRAI, supports tumor assessment for clinical care providers.
LivAi holds an advantage because its single MRAI suite reaches both oncology treatment monitoring and pharmaceutical drug development. That suite is cloud-based AI software covering the oncology path from diagnosis and prognosis through drug-response prediction. The MRAI Analytics Platform also carries pharma support through the entire development cycle and into clinical trial management.
ONCOassist places an oncologist's decision tools, guidelines, and calculators in one place, while Onc.AI's Onclara platform trains predictive and prognostic AI models on a real-world oncology dataset.
LivAi's MRAI solution competes with ONCOassist and OncRef for oncology clinical decision support, differing through MRAI analysis for detailed tumor assessment across the entire patient journey. The solution serves hospitals and clinics as clinical decision support for oncology treatment management.
ONCOassist gives oncology professionals instant information at the point of care, while OncRef Clinical curates cancer trials, approvals and guideline updates at the point of care. Onc.AI works as a digital health company to improve oncology decision making, and Bioxydyn delivers quantitative MRI biomarker studies to pharmaceutical and clinical research.
The risk to LivAi's MRAI solution, which serves hospitals and clinics as oncology clinical decision support, is ONCOassist, which consolidates an oncologist's decision tools, guidelines and calculators in one place, and OncRef Clinical's curated cancer trials, approvals and guideline updates at the point of care.
The Healthcare IT award was presented to LivAi's Dr. Robert Brown as its recipient.
LivAi provides cloud-based oncology AI software—a suite that converts oncology imaging into diagnostic, prognostic, drug-response prediction, and treatment-monitoring insight for care teams and pharmaceutical developers.
MRAI Diagnostic Solutions provides clinical decision support to hospitals and clinics for managing oncology treatment and assessing tumors, while the MRAI Analytics Platform supports pharmaceutical companies through drug development plus clinical trial management using oncology AI.